New data for investigational nipocalimab in Sjögren's Disease (SjD) and new research on the impact of TREMFYA® (guselkumab) in psoriatic arthritis (PsA) will be highlighted across three oral sessions ...

Resilient and promising, Cardano (ADA) has been a common pick among long-term investors. ADA, which is currently trading at $0.3527, has increased over 3% over ...

Report Ocean has published a new report on the Extracellular Matrix Market ... ECM-based products like scaffolds and hydrogels are now being used in advanced wound care to enhance the healing process ...